13F-HR filed by Madison Avenue Partners, LP
Madison Avenue Partners, LP filed this 13F-HR for the quarter ended 2024-09-30, filed 2024-11-14, with 25 holding rows worth $1,078,299,594.
- Accession
- 0001801265-24-000012
- Filer
- CIK 1801265
- Filed
- 2024-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2024
A holdings report, 25 entries on the cover page, a total value of $1,078,299,594 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,078,299,594 with VALUE read as dollars as filed, 13F file number 028-20035. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| SOLVENTUM CORP COM SHS | 83444M101 | Stock | 2,827,672 | $197,145,292 | dollars as filed | |
| GRAHAM HLDGS CO COM CL B | 384637104 | Stock | 235,271 | $193,326,887 | dollars as filed | |
| LIBERTY BROADBAND CORP | 530307305 | COM SER C | 1,696,584 | $131,128,978 | dollars as filed | |
| WILEY JOHN & SONS INC | 968223206 | CL A | 2,290,206 | $110,502,440 | dollars as filed | |
| GLOBUS MED INC CL A | 379577208 | Stock | 1,137,050 | $81,344,557 | dollars as filed | |
| THERAVANCE BIOPHARMA INC | G8807B106 | COM | 9,511,150 | $76,659,869 | dollars as filed | |
| STAGWELL INC | 85256A109 | COM CL A | 7,147,662 | $50,176,588 | dollars as filed | |
| QUIDELORTHO CORP COM | 219798105 | Stock | 1,033,382 | $47,122,220 | dollars as filed | |
| Indivior PLC | G4766E116 | Common Stock | 3,960,772 | $38,617,527 | dollars as filed | |
| NELNET INC | 64031N108 | CL A | 290,213 | $32,875,329 | dollars as filed | |
| DUCOMMUN INC DEL | 264147109 | COM | 363,729 | $23,944,281 | dollars as filed | |
| ENDEAVOR GROUP HLDGS INC | 29260Y109 | CL A COM | 730,260 | $20,856,226 | dollars as filed | |
| INNOVEX INTERNATIONAL INC | 457651107 | COM | 1,024,467 | $15,039,176 | dollars as filed | |
| 2SEVENTY BIO INC COMMON STOCK | 901384107 | Stock | 2,563,222 | $12,098,408 | dollars as filed | |
| NEWS CORP NEW CL A | 65249B109 | Stock | 428,040 | $11,398,706 | dollars as filed | |
| AMENTUM HOLDINGS INC COM | 023939101 | Stock | 383,218 | $11,067,336 | dollars as filed | |
| REVANCE THERAPEUTICS INC | 761330109 | COM | 1,353,321 | $7,023,736 | dollars as filed | |
| FRANKLIN STR PPTYS CORP | 35471R106 | COM | 3,291,443 | $5,825,855 | dollars as filed | |
| OVID THERAPEUTICS INC | 690469101 | COMMON STOCK | 4,116,773 | $4,857,793 | dollars as filed | |
| ModivCare Inc | 60783X104 | Common Stock | 261,511 | $3,734,378 | dollars as filed | |
| NEWS CORP NEW | 65249B208 | CL B | 52,534 | $1,468,326 | dollars as filed | |
| THE CENTRAL AND EASTERN EU I | 153436100 | COM | 79,400 | $851,168 | dollars as filed | |
| SHARKNINJA INC COM SHS | G8068L108 | Stock | 6,152 | $668,784 | dollars as filed | |
| TALKSPACE INC | 87427V103 | COM | 257,238 | $537,628 | dollars as filed | |
| ZIMVIE INC | 98888T107 | COM | 1,771 | $28,106 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001801265-24-000012 | this filing | 2024-11-14 | acceptance time not in the bulk data set |